COMMUNIQUÉS West-GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

16/04/2025 - 22:05

BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16/04/2025 - 22:05

CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore [...]

Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

16/04/2025 - 22:32

SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease

16/04/2025 - 22:44

BUENOS AIRES, Argentina, April 16, 2025 (GLOBE NEWSWIRE) -- Biosidus , an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging [...]

FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K

16/04/2025 - 23:45

WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025. Pursuant to the [...]

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®

16/04/2025 - 17:45

Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 [...]

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

16/04/2025 - 17:45

Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place [...]

Correction: Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025

16/04/2025 - 18:36

ERRATUM – ANNULE ET REMPLACE Nous regrettons une erreur dans le tableau inclus dans le communiqué de presse en français. Merci de le remplacer par celui-ci. Croissance des ventes de 11,6% à taux de change constant 1 , [...]

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

16/04/2025 - 18:45

CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]

SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€

16/04/2025 - 19:00

Communiqué de presse Ecully, le 16 avril 2025 – 19h SPINEWAY Chiffre d’affaires du 1 er trimestre 2025 de 2,8 M€ En milliers d’euros 2025 2024 Variation en % CA 1 er trimestre 2 828 3 070 - 8% Données consolidées non [...]

Spineway : First-quarter 2025 revenue of €2.8 million

16/04/2025 - 19:10

Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros 2025 2024 Change as a % Q1 revenue 2,828 3,070 -8% Unaudited consolidated data Spineway, a [...]

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

16/04/2025 - 19:21

Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]

Dyadic to Present at World Vaccine Congress | Washington

16/04/2025 - 20:00

JUPITER, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company that utilizes its microbial production platforms to [...]

Vaxart to Present at World Vaccine Congress Washington 2025 on April 23

16/04/2025 - 14:00

SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, [...]

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

16/04/2025 - 14:00

FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, [...]

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

16/04/2025 - 14:30

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this [...]

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

16/04/2025 - 14:30

New patent underscores breadth of application and expansion opportunities for Company’s catheter-based technology Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent [...]

Conduit Pharmaceuticals Announces Leadership Changes

16/04/2025 - 14:30

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (" Conduit Pharmaceuticals " or " Conduit " or the " Company ") today announced key leadership [...]

Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company

16/04/2025 - 14:30

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company’s LIBERATE- [...]